Saturday 17 October 2026 Export REGN’s income statement to Excel — free account

Regeneron Pharmaceuticals, Inc.

Regeneron Pharmaceuticals, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $14.3 billion, up 0.99% from fiscal 2024. In the quarter to June 2026, revenue grew 16.7%, EPS fell 4.68%, free cash flow fell 29.3% and total debt fell 26.6%, each against the same quarter a year earlier. Member of the S&P 500 and Nasdaq 100; revenue growth for three consecutive years.

790.74 5.60 −0.70%

Follow REGN

Alert me

Market cap: $82.0B
P/E: 18.9×
Fwd P/E: 16.5×
Dividend yield: 0.47%
F-score: 5/9
Altman Z: 7.49
Beneish M: −2.53
Dividend safety: 77/100

Overview Business Profile Financial Analysis Income Statement Balance Sheet Cash Flow Metrics & Ratios Filings 10-Q 10-K

	Jun '26	Mar '26	Dec '25	Sep '25	Older periods
ROE Full definition →	14.04%	14.55%	14.87%	15.19%	+8 more TTM periods Free account
Piotroski F-Score Full definition →	6	5	5	5
ROA Full definition →	10.83%	11.28%	11.50%	11.80%
ROIC Full definition →	9.34%	9.20%	8.82%	9.14%
Return on Tangible Assets Full definition →	23.56%	24.08%	24.00%	24.67%
Average Days of Receivables Full definition →	154.26	140.21	146.10	145.69
Free Cash Flow per Share Full definition →	34.78	36.45	36.00	37.46
Free Cash Flow Full definition →	3,575.20	3,791.00	3,765.20	3,881.00
Capital Expenditures Full definition →	(1,106.10)	(1,221.70)	(1,213.70)	(1,190.00)
Other line items
Cash ROIC Full definition →	8.58%	8.99%	8.85%	9.22%
Accounts Receivable Turnover Full definition →	2.55	2.64	2.40	2.42
Accounts Payable Turnover Full definition →	2.50	2.66	2.43	2.97
Inventory Turnover Full definition →	0.75	0.73	0.67	0.66
Average Days of Payables Full definition →	179.90	162.59	163.15	158.49
Days of Inventory on Hand Full definition →	478.62	491.29	556.14	570.67
Tax Rate Full definition →	(0.16)	(0.14)	(0.14)	(0.11)
Research and Development Expense of Revenue Full definition →	40.40%	40.66%	40.79%	39.56%
Selling, General and Administrative Expense of Revenue Full definition →	17.65%	18.20%	18.82%	19.07%
Share Based Compensation of Revenue Full definition →	6.35%	6.67%	6.93%	7.36%
Interest Coverage Full definition →	69.37	75.61	81.69	87.61
Operating CF/Net income Full definition →	1.08	1.13	1.11	1.11
Depreciation/Fixed assets Full definition →	0.10	0.10	0.11	0.11
Capex/Depreciation Full definition →	(2.09)	(2.26)	(2.23)	(2.27)
Revenue per Share Full definition →	151.12	143.46	137.12	137.53
Operating CF per Share Full definition →	45.54	48.20	47.60	48.95
Capex per Share Full definition →	(10.76)	(11.75)	(11.60)	(11.49)
Capex to Sales Full definition →	0.07	0.08	0.08	0.08

Show all line items

Columns are period end dates

Stockrow Weekly